C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
03/1997
03/19/1997	EP0573464B1 Process for preparing trans-piperidine-2,5-dicarboxylates
03/13/1997	WO1997009297A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/12/1997	EP0761766A2 Asymmetric triphenylenedioxazine compounds
03/12/1997	EP0761671A1 Cephem derivatives
03/12/1997	CN1144801A Beta-Adrenergic agonists
03/06/1997	WO1997008144A1 Substituted benzylaminopiperidine compounds
03/04/1997	US5607956 1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents
03/04/1997	CA2166794C Magnesium omeprazole
02/1997
02/26/1997	EP0533781B1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
02/20/1997	WO1997006162A1 One pot synthesis of 2-oxazolidinone derivatives
02/20/1997	WO1997006160A1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
02/19/1997	EP0758327A1 Pyranone compounds useful to treat retroviral infections
02/19/1997	CN1034077C Preparation of new pyrido\|2,3-f¨\|1,4¨ thiazepines
02/19/1997	CN1034072C Preparing method for tetrahydrocarbazole derivative
02/18/1997	US5604223 Treating epilepsy, nervous system disorder
02/18/1997	US5604217 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation
02/13/1997	WO1997004788A2 Use of calendula glycosides for the treatment of psoriasis
02/13/1997	CA2227751A1 Use of calendula glycosides for the treatment of psoriasis
02/12/1997	EP0757684A1 Process for the diastereoselective synthesis of nucleoside analogues
02/12/1997	EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
02/12/1997	CN1142821A Method of synthesizing gamma pyrones
02/12/1997	CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo\|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines
02/12/1997	CN1142492A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents
02/06/1997	WO1997003959A1 Crystalline [r-(r,r)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
02/06/1997	WO1997003958A1 Form iii crystalline (r-(r,r)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
02/06/1997	WO1997003654A2 Pharmaceutical compositions
02/05/1997	EP0756595A1 Substituted 1,3-oxathiolanes with antiviral properties
02/05/1997	EP0756594A1 Preparation of arthropodicidal oxadiazines
02/05/1997	CN1141918A Amide compounds for medical treatment
01/1997
01/30/1997	WO1997003084A1 New inhibitors of platelet aggregation
01/30/1997	CA2226758A1 New inhibitors of platelet aggregation
01/28/1997	US5597828 Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which are pharmacologically active CNS compounds
01/28/1997	US5597827 Treatment of injury of the spinal cord or brain using 4-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine
01/28/1997	US5597779 Sulfonylureas
01/23/1997	WO1997002241A1 Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
01/22/1997	EP0754183A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug
01/22/1997	CN1141040A 6-substituted mycophenolic and derivatives with immunosuppressive activity
01/22/1997	CN1140709A Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents
01/21/1997	US5596103 Chemical condensation of tetrazole ester and cyclization in the presence of acid
01/21/1997	US5595999 Guanidine derivatives
01/16/1997	WO1997001540A1 Integrin receptor antagonists
01/15/1997	CN1140448A New compounds with analgesic and local anaesthetic effect
01/15/1997	CN1140175A 7-acyl-3-(substd. carbamoyloxy) cephem compounds and their preparation process
01/15/1997	CN1140165A Arylsulfonyl hydroxamic acid derivatives
01/15/1997	CN1140164A Antiarrhythmic and cardioprotective substituted indenoyiguanidines
01/15/1997	CN1033805C Herbicide composition cotng. new substd. pyrazolyl pyrazole, its preparation process and application
01/14/1997	US5594157 Process for making taxol derivatives
01/14/1997	CA1338842C Cephem compound and a process for preparation thereof
01/08/1997	CN1139926A Pyridine derivatives as pesticides
01/08/1997	CN1139925A 'Delta' 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
01/07/1997	US5591746 Glutamate inhibitors; central nervous system disorders
01/07/1997	CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles
01/01/1997	CN1138983A Preparation of drug composition
12/1996
12/25/1996	CN1033640C 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties
12/24/1996	US5587483 Process for preparing tetrazol-5-yl substituted benzopyran compounds
12/24/1996	US5587480 Treating hiv and hepatitis virus infections
12/24/1996	US5587473 Blocking; condensation; deblocking
12/24/1996	US5587380 Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds
12/19/1996	WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996	WO1996040659A1 N-hydroxyureas as antiinflammatory agents
12/19/1996	CA2220958A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/18/1996	EP0748806A1 POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
12/12/1996	WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996	WO1996039406A1 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
12/12/1996	WO1996039385A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
12/12/1996	WO1996039384A1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
12/11/1996	EP0747383A2 Polyamine salts of clavulanic acid
12/11/1996	EP0669924B1 Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
12/11/1996	EP0644887B1 Intermediates in a process for the purification of clavulanic acid
12/11/1996	CN1033509C Process for preparation of water soluble camptothecin analogs
12/10/1996	US5583133 Anticoagulants
12/10/1996	CA2023217C Azabicyclo quinolone carboxylic acids
12/04/1996	EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/04/1996	CN1137037A Quinazoline derivatives
12/04/1996	CN1033454C Process for preparing 4-\|(2-benzothiazolyl) methylamino¨-alpha-\|(3,4-difluorophinoxy) methyl¨-1-piperidineethanol
12/03/1996	US5580978 Alcoholysis; 7-amino-3-alkoxymethylcephem-4-carboxylic acid derivative
12/03/1996	US5580889 Insecticidal nitromethyl or niteoimino-heteromethyl-heterocyclics
12/03/1996	CA1338764C Polyamine derivatives
11/1996
11/27/1996	EP0743940A1 New compounds with analgesic and local anaesthetic effect
11/27/1996	CN1136775A Treatment of allergic disorders with terfenadine carboxylate
11/27/1996	CN1136562A Estrogen excitant/antagonist
11/26/1996	US5578594 Anticoagulants
11/26/1996	US5578582 Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives
11/19/1996	CA2106200C Stereoselective preparation of substituted piperidines
11/19/1996	CA2080249C Preparation of substituted piperidines
11/14/1996	WO1996035671A1 β-ADRENERGIC AGONISTS
11/14/1996	WO1996035670A1 β-ADRENERGIC AGONISTS
11/14/1996	CA2220538A1 .beta.-adrenergic agonists
11/14/1996	CA2220399A1 .beta.-adrenergic agonists
11/13/1996	EP0741717A1 Method of synthesizing gamma pyrones
11/13/1996	EP0741716A1 Delta 12,13 -iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
11/13/1996	CN1033272C Method of producing 5'-nucleotide
11/07/1996	WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996	WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/06/1996	CN1135218A Piperidine derivatives
10/1996
10/30/1996	EP0538301B1 Hiv-inhibiting benzeneacetamide derivatives
10/30/1996	CN1033142C Process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus
10/29/1996	US5569672 Human and animal growth promoters; calcium pseudomonate
10/29/1996	US5569657 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
10/24/1996	WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors

1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 105